X-STATIC ® SILVER ANTIMICROBIAL TECHNOLOGY PROVIDES INFECTION PREVENTION BENEFITS FOR HEALTHCARE

(SCRANTON, PA) X-STATIC®, the silver-based fiber technology used widely by US Military Forces, Olympic Athletes, NASA astronauts and hundreds of well-known consumer brands, is now available to the healthcare textile industry. Soft surfaces constitute 90 percent of the patient healthcare environment and include privacy curtains, lab coats, scrubs, bed linens and cubicle curtains. Clinical studies have proven these surfaces are highly contaminated by pathogenic organisms,[1],[2] which have the potential to transmit to patients and cause healthcare associated infections (HAIs). Healthcare associated infections take the lives of nearly 100,000 people annually and cost billions of dollars in additional medical treatments. Although hospitals continue efforts to improve infection control, standardized practices for soft surface bacterial management are inadequate compared with those for hand and environmental hygiene. Further, laundering practices are inconsistent and simply ineffective, as re-contamination occurs after laundered items are put into use.[2] Textiles made with X-STATIC® silver antimicrobial technology have been clinically-proven to inhibit the growth of bacteria directly on the surface of the fabric. X-STATIC delivers quick, comprehensive and permanent protection with a continuous release of silver ions that lasts for the life of the product. “Soft surfaces represent a clear gap in everyday infection prevention practice,” said Peg Luebbert, Infection Control Expert and Founder of Healthcare Interventions, Inc. “Hand washing/sanitization is only effective until a healthcare worker touches a contaminated soft surface through regular behaviors like opening a privacy curtain or retrieving a pen from a pocket. For example, if a healthcare worker washes his/her hands and then puts those hands in a contaminated uniform pocket before touching a patient, the risk of cross contamination still exists.”...

Noble Biomaterials Packs Up $8M On Strength Of 140-Year Track Record

By Timothy Hay, VentureWire February 10, 2012 Noble Biomaterials Inc., a 140-year-old textile company that has found new life as an advanced-materials developer, has raised an $8 million Series B round as it prepares to transform itself once again. Noble is likely to either go public or be acquired within the next three years, Chief Financial Officer Jim Walsh said. Operating from the same industrial corridor of Scranton, Pa., since 1880–when its main line of business was spinning silk–the company has changed hands several times over the decades and reinvented itself more than once. The Series B was provided by return investor TL Ventures and newcomers DuPont Capital Management and Northwater Capital Intellectual Property Fund, the company said. In 2005, TL Ventures helped transform the company into the advanced-materials player that it is today, company materials said. The firm helped merge Noble–then known as Noble Fiber Technologies–with Sauquoit Silk Co., another established textile company that had found success using synthetic fabrics like nylon. TL Ventures gave the newly formed entity more than $10 million in Series A funding and owns a significant stake in the company, Managing Director Robert Keith said. He declined to give a valuation for the company. The company’s core product today is a proprietary manufacturing process that involves bonding silver with nylon, the CFO said. Silver, once exposed to enhanced processing, has anti-microbial properties, meaning it can stave off infection. Fabrics that can kill germs have potential uses in a variety of industries, from sports to space travel to the military. Noble Biomaterials today has several distinct lines of business. In addition to selling fabrics...